Wang, Kai-Hung, et al
Biopolymer-based biomaterials for accelerated diabetic wound healing: a critical review
A rescue effect is observed in rats that are given Dihexa following scopolamine pretreatment
This receptor sensitization could contribute to the protein synthesis, cellular repair, and tissue regeneration outcomes observed across multiple preclinical models, from connective tissue to neural and smooth muscle
RNA bait-mediated SFB genome capture and Illumina and Pacbio sequencing A set of overlapping 99,922 120 bp-long RNA baits were designed and generated by ArborBiosciences based on the genome sequence of eight SFB (with the omission of small and large subunit ribosomal RNA genes islands) including five mouse SFB (SFB-YIT NCBI RefSeq assembly #GCF_000284435, SFB-Japan NCBI RefSeq assembly #GCF_0002270205, SFB-NL NCBI RefSeq assembly #GCF_000709435, SFB-NYU NCBI RefSeq assembly #GCF_000225365, and SFB-SU NCBI RefSeq assembly #GCF_000252785), one rat SFB (NCBI RefSeq assembly #GCF_000283555), one turkey SFB (NCBI RefSeq assembly #GCF_001655775) and the draft human Mali SFB S340 sequence generated by chromosome conformation capture
MECHANISM CATEGORIES SAFETY Side effects GI: nausea, vomiting (titration-dependent) Injection-site reactions Hypoglycemia risk when combined with insulin Known interactions Insulin additive hypoglycemia risk Contraindications History of MTC or MEN2 (theoretical class effect) REGULATORY STATUS FDA Not yet FDA-approved as of 2026-05
